Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Sponsor
Clinical Trial Start Date
2003
0Primary Completion Date
2005
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Interventional Trial Phase
Phase 10
Official Name
Phase I Pharmacology Study Of Oral And Intravenous BCX-1777 In Patients With Refractory T-Cell And Non-T-Cell Malignancies0
Last Updated
May 30, 2013
0Masking Type
None (Open Label)0
Study summary
RATIONALE: BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: Phase I trial to study the effectiveness of BCX-1777 in treating patients who have refractory cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
